Following publication of the original article [1], the authors reported an error in the spelling of Lorenzo Dagna's name. The authors apologise for the error. Incorrect spelling: Loreno Dagna Correct spelling: Lorenzo Dagna The original article [1] has been updated.

Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease (Arthritis Research and Therapy (2019) 21 (54) DOI: 10.1186/s13075-019-1843-9)

Cavalli, Giulio
;
De Luca, Giacomo;Dagna, Lorenzo
2019-01-01

Abstract

Following publication of the original article [1], the authors reported an error in the spelling of Lorenzo Dagna's name. The authors apologise for the error. Incorrect spelling: Loreno Dagna Correct spelling: Lorenzo Dagna The original article [1] has been updated.
2019
Inglese
BioMed Central Ltd.
21
1
69
Pubblicato
http://arthritis-research.com/
Internazionale
Rheumatology; Immunology and Allergy; Immunology
none
7
info:eu-repo/semantics/article
262
Cavalli, Giulio; Tomelleri, Alessandro; De Luca, Giacomo; Campochiaro, Corrado; Dinarello, Charles A.; Baldissera, Elena; Dagna, Lorenzo
1 Contributo su Rivista::1.1.5. Erratum
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/110685
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact